These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25503175)

  • 21. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
    Pederson AW; Fricano J; Correa D; Pelizzari CA; Liauw SL
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):235-41. PubMed ID: 21163587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
    Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human collagen injections to reduce rectal dose during radiotherapy.
    Noyes WR; Hosford CC; Schultz SE
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1918-22. PubMed ID: 21514738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
    J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer.
    Hamstra DA; Stenmark MH; Ritter T; Litzenberg D; Jackson W; Johnson S; Albrecht-Unger L; Donaghy A; Phelps L; Blas K; Halverson S; Marsh R; Olson K; Feng FY
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1246-53. PubMed ID: 23265567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.
    Crehange G; Mirjolet C; Gauthier M; Martin E; Truc G; Peignaux-Casasnovas K; Azelie C; Bonnetain F; Naudy S; Maingon P
    Radiother Oncol; 2012 May; 103(2):244-6. PubMed ID: 22119374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
    Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal dose variation during the course of image-guided radiation therapy of prostate cancer.
    Chen L; Paskalev K; Xu X; Zhu J; Wang L; Price RA; Hu W; Feigenberg SJ; Horwitz EM; Pollack A; Ma CM
    Radiother Oncol; 2010 May; 95(2):198-202. PubMed ID: 20303193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis and Management of Rectal Gas with Kampo Formulas During Intensity-Modulated Radiotherapy of Prostate Cancer: A Case Series Study.
    Nagai A; Shibamoto Y; Ogawa K; Inoda K; Yoshida M; Kikuchi Y
    J Altern Complement Med; 2016 Jun; 22(6):480-5. PubMed ID: 27110721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second Tumor Induction Risk in IMRT for Prostate Cancer: An Unbalanced Comparison Between Surgery and Radiotherapy?
    Calandrino R; Perna L; Belli ML; Botti A; Cattaneo M; Fiorino C; Cozzarini C; Iori M
    Health Phys; 2015 Dec; 109(6):549-55. PubMed ID: 26509622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of gold radionuclide markers implanted into the prostate for image-guided radiotherapy in prostate cancer: side effects caused by the marker implantation].
    Kliton J; Ágoston P; Szabó Z; Major T; Polgár C
    Magy Onkol; 2014 Sep; 58(3):182-7. PubMed ID: 25260082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of prostate calcification with megavoltage helical CT.
    Hama Y
    Acad Radiol; 2014 May; 21(5):565-8. PubMed ID: 24703468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer.
    Maruoka S; Yoshioka Y; Isohashi F; Suzuki O; Seo Y; Otani Y; Akino Y; Takahashi Y; Sumida I; Ogawa K
    Springerplus; 2015; 4():579. PubMed ID: 26543714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of artificial intelligence-driven interfractional monitoring of organ changes by mega-voltage computed tomography in intensity-modulated radiotherapy of prostate cancer.
    Lee Y; Choi HJ; Kim H; Kim S; Kim MS; Cha H; Eum YJ; Cho H; Park JE; You SH
    Radiat Oncol J; 2023 Sep; 41(3):186-198. PubMed ID: 37793628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective observational study to analyse the influence of bladder and rectal volume changes on prostate radiotherapy using IMRT.
    Arya R; Goyal H; Naik A; Gurjar OP
    Rep Pract Oncol Radiother; 2020; 25(3):312-317. PubMed ID: 32194351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimization of MVCT imaging schedule in prostate cancer treatment using helical tomotherapy].
    Beldjoudi G; Yartsev S; Battista JJ; Van Dyk J
    Cancer Radiother; 2008 Sep; 12(5):316-22. PubMed ID: 18436466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical examination of cases of radiation proctitis after intensity-modulated radiation therapy for prostate cancer].
    Suko S; Eguchi H; Yoshida K; Uehara M; Itoshima H; Koga T; Muraoka M; Kudo K; Kamikawa K; Imamura H
    Nihon Shokakibyo Gakkai Zasshi; 2015 Jul; 112(7):1299-308. PubMed ID: 26155862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.